Literature DB >> 3586612

Muscle necrosis in Syrian hamsters resulting from intramuscular injections of ketamine and xylazine.

D J Gaertner, K R Boschert, T R Schoeb.   

Abstract

To assess tissue damage resulting from intramuscular injection of mixtures of ketamine and xylazine, 48 hamsters were given 100, 150 or 200 mg/kg ketamine and 10 mg/kg xylazine in one hind leg and an equal volume of sterile physiologic saline in the other leg. Four hamsters from each group were killed 1, 3, 7 and 14 days after injection and the tissues at the injection sites were examined. There was grossly apparent muscle necrosis in most of the ketamine-xylazine injected legs. By light microscopy, 47 of 48 legs injected with ketamine-xylazine had moderate to extensive muscle necrosis with an acute to chronic inflammatory response, depending on the time elapsed since injection. Microscopic slides of the injection sites were coded, randomized and scored for severity of muscle lesions. Lesion scores for ketamine-xylazine injected legs were significantly higher than controls at all post-injection times. These findings indicate that intramuscular injection of ketamine with xylazine can cause extensive muscle necrosis in hamsters and should not be used for anesthesia in survival procedures.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3586612

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  8 in total

1.  Self-mutilation in rabbits following intramuscular ketamine-xylazine-acepromazine injections.

Authors:  P Vachon
Journal:  Can Vet J       Date:  1999-08       Impact factor: 1.008

2.  Administration of substances to laboratory animals: routes of administration and factors to consider.

Authors:  Patricia V Turner; Thea Brabb; Cynthia Pekow; Mary Ann Vasbinder
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-09       Impact factor: 1.232

3.  Comparison of Isoflurane, Ketamine-Dexmedetomidine, and Ketamine-Xylazine for General Anesthesia during Oral Procedures in Rice Rats (Oryzomys palustris).

Authors:  Jessica M Jiron; Jorge L Mendieta Calle; Evelyn J Castillo; Abel M Abraham; Jonathan G Messer; Wendi L Malphurs; Carolyn Malinowski; Kristina Grove; Leah R Reznikov; Jasenka Zubcevic; J Ignacio Aguirre
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-12-20       Impact factor: 1.232

4.  Evaluation of Volume of Intramuscular Injection into the Caudal Thigh Muscles of Female and Male BALB/c Mice (Mus musculus).

Authors:  Alicia M Gehling; Kyle Kuszpit; Emily J Bailey; Krystal H Allen-Worthington; David P Fetterer; Pedro J Rico; Thomas M Bocan; Christian C Hofer
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-01-01       Impact factor: 1.232

5.  Beyond-use dating of extemporaneously compounded ketamine, acepromazine, and xylazine: safety, stability, and efficacy over time.

Authors:  Brett J Taylor; Steven A Orr; Jennifer L Chapman; Diana E Fisher
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-11       Impact factor: 1.232

6.  Comparison of ketamine-xylazine and ketamine-dexmedetomidine anesthesia and intraperitoneal tolerance in rats.

Authors:  David Wellington; Igor Mikaelian; Laura Singer
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-07       Impact factor: 1.232

7.  Effects of isoflurane, ketamine-xylazine and a combination of medetomidine, midazolam and fentanyl on physiological variables continuously measured by telemetry in Wistar rats.

Authors:  Maike Albrecht; Julia Henke; Sabine Tacke; Michael Markert; Brian Guth
Journal:  BMC Vet Res       Date:  2014-08-23       Impact factor: 2.741

8.  Impact of repeated anesthesia with ketamine and xylazine on the well-being of C57BL/6JRj mice.

Authors:  Katharina Hohlbaum; Bettina Bert; Silke Dietze; Rupert Palme; Heidrun Fink; Christa Thöne-Reineke
Journal:  PLoS One       Date:  2018-09-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.